ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. It also offers a proprietary portfolio and a pipeline of targeted treatments in various stages of clinical development that address a range of cancers such as neuroendocrine cancers or bone metastases.